Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1994 2
1995 1
2001 3
2011 1
2012 3
2013 1
2014 5
2015 4
2018 5
2019 1
2020 1
2021 6
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial.
Montravers P, Tubach F, Lescot T, Veber B, Esposito-Farèse M, Seguin P, Paugam C, Lepape A, Meistelman C, Cousson J, Tesniere A, Plantefeve G, Blasco G, Asehnoune K, Jaber S, Lasocki S, Dupont H; DURAPOP Trial Group. Montravers P, et al. Among authors: esposito farese m. Intensive Care Med. 2018 Mar;44(3):300-310. doi: 10.1007/s00134-018-5088-x. Epub 2018 Feb 26. Intensive Care Med. 2018. PMID: 29484469 Free article. Clinical Trial.
Case-only designs in pharmacoepidemiology: a systematic review.
Nordmann S, Biard L, Ravaud P, Esposito-Farèse M, Tubach F. Nordmann S, et al. Among authors: esposito farese m. PLoS One. 2012;7(11):e49444. doi: 10.1371/journal.pone.0049444. Epub 2012 Nov 16. PLoS One. 2012. PMID: 23166668 Free PMC article. Review.
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications.
Plessier A, Esposito-Farèse M, Baiges A, Shukla A, Garcia Pagan JC, De Raucourt E, Ollivier-Hourmand I, Cervoni JP, De Ledinghen V, Tazi Z, Nousbaum JB, Bun R, Bureau C, Silvain C, Tournilhac O, Gerfaud-Valentin M, Durand F, Goria O, Tellez L, Albillos A, Gioia S, Riggio O, De Gottardi A, Payance A, Rautou PE, Terriou L, Charbonnier A, Elkrief L, de la Tour RP, Valla DC, Gault N, de Fontbrune FS. Plessier A, et al. Among authors: esposito farese m. Am J Hematol. 2022 Apr;97(4):431-439. doi: 10.1002/ajh.26474. Epub 2022 Jan 31. Am J Hematol. 2022. PMID: 35049058 Free article.
Genome wide association study of Escherichia coli bloodstream infection isolates identifies genetic determinants for the portal of entry but not fatal outcome.
Denamur E, Condamine B, Esposito-Farèse M, Royer G, Clermont O, Laouenan C, Lefort A, de Lastours V, Galardini M; COLIBAFI; SEPTICOLI groups. Denamur E, et al. Among authors: esposito farese m. PLoS Genet. 2022 Mar 24;18(3):e1010112. doi: 10.1371/journal.pgen.1010112. eCollection 2022 Mar. PLoS Genet. 2022. PMID: 35324915 Free PMC article.
Risk factors for therapeutic failure in the management of post-operative peritonitis: a post hoc analysis of the DURAPOP trial.
Montravers P, Esposito-Farèse M, Lasocki S, Grall N, Veber B, Eloy P, Seguin P, Weiss E, Dupont H; DURAPOP trial group. Montravers P, et al. Among authors: esposito farese m. J Antimicrob Chemother. 2021 Nov 12;76(12):3303-3309. doi: 10.1093/jac/dkab307. J Antimicrob Chemother. 2021. PMID: 34458922 Free PMC article. Clinical Trial.
37 results